Cancer Biology and Medicine : Impact Factor & More
eISSN: 2095-3941pISSN: 2095-3941
Open AccessShare this on:
Key Metrics
CiteScore 
6.5
SNIP
1.13
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cancer Biology and Medicine
Cancer Biology and Medicine Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | CHINA ANTI-CANCER ASSOC |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | USD 1500 |
| Publication Time | 12 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Cancer Biology and Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Biology and Medicine
HBx-mediated GPT2 suppression promotes liver cancer development by downregulating ADH1A.
- 19 May 2026
- Cancer biology & medicine
CAMK2D isoform 15 facilitates gefitinib resistance via AKT phosphorylation in lung adenocarcinoma.
- 18 May 2026
- Cancer biology & medicine
VAMP2/SNAP25 promotes the aggressive progression of head and neck cancer by regulating the fate of multivesicular bodies.
- 12 May 2026
- Cancer biology & medicine
Lenvatinib triggers an EGR1-ZNF768-SLC7A11 adaptive response to limit ferroptosis-mediated therapeutic efficacy in hepatocellular carcinoma.
- 11 May 2026
- Cancer biology & medicine
Induction immunochemotherapy followed by definitive radiotherapy in patients with limited-stage small cell lung cancer: a multicenter study.
- 11 May 2026
- Cancer biology & medicine
Probiotics in colorectal cancer: mechanisms, biomarkers, and adjunct strategies.
- 7 May 2026
- Cancer biology & medicine
HBx-mediated GPT2 suppression promotes liver cancer development by downregulating ADH1A.
- 19 May 2026
- Cancer biology & medicine
CAMK2D isoform 15 facilitates gefitinib resistance via AKT phosphorylation in lung adenocarcinoma.
- 18 May 2026
- Cancer biology & medicine
VAMP2/SNAP25 promotes the aggressive progression of head and neck cancer by regulating the fate of multivesicular bodies.
- 12 May 2026
- Cancer biology & medicine
Lenvatinib triggers an EGR1-ZNF768-SLC7A11 adaptive response to limit ferroptosis-mediated therapeutic efficacy in hepatocellular carcinoma.
- 11 May 2026
- Cancer biology & medicine
Induction immunochemotherapy followed by definitive radiotherapy in patients with limited-stage small cell lung cancer: a multicenter study.
- 11 May 2026
- Cancer biology & medicine
Probiotics in colorectal cancer: mechanisms, biomarkers, and adjunct strategies.
- 7 May 2026
- Cancer biology & medicine
FAQs on Cancer Biology and Medicine
How long has Cancer Biology and Medicine been actively publishing? 
What is the publishing frequency of Cancer Biology and Medicine?
How many articles did Cancer Biology and Medicine publish last year?
What is the eISSN & pISSN for Cancer Biology and Medicine?
What is Citescore for Cancer Biology and Medicine?
What is SNIP score for Cancer Biology and Medicine?
Who is the publisher of Cancer Biology and Medicine?
